难治性-话题@MedSci

#难治性#

683篇内容 | 2686人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1528482, encodeId=c6b0152848228, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：Quizartinib单药治疗复发性/难治性FLT3-ITD突变型急性髓系白血病的效果和安全性, objectType=article, longId=140256, objectId=0af5140256d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0af5140256d5, replyNumber=0, likeNumber=28, createdTime=2018-06-09, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0af5140256d5, moduleTitle=Blood：Quizartinib单药治疗复发性/难治性FLT3-ITD突变型急性髓系白血病的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0af5140256d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528481, encodeId=58f31528481dd, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Hypertension：利尿剂对难治性高血压（RfHTN）也是束手无策！, objectType=article, longId=140208, objectId=6cad140208de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cad140208de, replyNumber=0, likeNumber=69, createdTime=2018-06-08, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cad140208de, moduleTitle=Hypertension：利尿剂对难治性高血压（RfHTN）也是束手无策！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cad140208de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528480, encodeId=81a51528480d4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet oncol：卡非佐米，每周一次，比每周两次，可显著延长复发性/难治性多发性骨髓瘤患者的无进展存活期, objectType=article, longId=139819, objectId=01201398198e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01201398198e, replyNumber=0, likeNumber=82, createdTime=2018-06-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01201398198e, moduleTitle=Lancet oncol：卡非佐米，每周一次，比每周两次，可显著延长复发性/难治性多发性骨髓瘤患者的无进展存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01201398198e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528479, encodeId=9ae415284e995, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JCC：英夫利昔单抗的清除加速与皮质类固醇难治性急性溃疡性结肠炎患者的治疗失败有关, objectType=article, longId=139805, objectId=2b121398052a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b121398052a, replyNumber=0, likeNumber=77, createdTime=2018-06-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b121398052a, moduleTitle=JCC：英夫利昔单抗的清除加速与皮质类固醇难治性急性溃疡性结肠炎患者的治疗失败有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b121398052a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528478, encodeId=cb6115284e8f9, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet oncol：Quizartinib，FLT3抑制剂，单独用于复发性/难治性急性髓系白血病患者可获得良好疗效, objectType=article, longId=139563, objectId=4056139563b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4056139563b2, replyNumber=0, likeNumber=54, createdTime=2018-06-02, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4056139563b2, moduleTitle=Lancet oncol：Quizartinib，FLT3抑制剂，单独用于复发性/难治性急性髓系白血病患者可获得良好疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4056139563b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528477, encodeId=cc6615284e73d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet Child Adol Health：依维莫司用于难治性癫痫合并结节性硬化症患儿的辅助治疗, objectType=article, longId=139024, objectId=84d813902457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d813902457, replyNumber=0, likeNumber=80, createdTime=2018-05-26, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d813902457, moduleTitle=Lancet Child Adol Health：依维莫司用于难治性癫痫合并结节性硬化症患儿的辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84d813902457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528476, encodeId=2c3915284e6e4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=突然发呆或是癫痫，难治性癫痫如何治疗？, objectType=article, longId=138753, objectId=5015138e5384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5015138e5384, replyNumber=0, likeNumber=85, createdTime=2018-05-23, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5015138e5384, moduleTitle=突然发呆或是癫痫，难治性癫痫如何治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5015138e5384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528475, encodeId=0b9e15284e5d9, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Ann Pharmacother：治疗肠梗阻、ACPO或难治性便秘新斯的明给药方式有讲究, objectType=article, longId=138503, objectId=a01113850386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a01113850386, replyNumber=0, likeNumber=54, createdTime=2018-05-20, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a01113850386, moduleTitle=Ann Pharmacother：治疗肠梗阻、ACPO或难治性便秘新斯的明给药方式有讲究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a01113850386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528474, encodeId=9fc415284e44d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：脐带血移植为难治性重度再生障碍性贫血患者带来新的希望, objectType=article, longId=138189, objectId=ac2913818957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac2913818957, replyNumber=0, likeNumber=71, createdTime=2018-05-17, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac2913818957, moduleTitle=Blood：脐带血移植为难治性重度再生障碍性贫血患者带来新的希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac2913818957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528473, encodeId=df3515284e31b, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：博纳吐单抗用于复发性/难治性急性淋巴细胞白血病成年患者不仅可延长其存活期，还可改善其生活质量, objectType=article, longId=137632, objectId=d12113e632d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12113e632d1, replyNumber=0, likeNumber=58, createdTime=2018-05-11, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12113e632d1, moduleTitle=Blood：博纳吐单抗用于复发性/难治性急性淋巴细胞白血病成年患者不仅可延长其存活期，还可改善其生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d12113e632d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528472, encodeId=d03f15284e2f8, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Ophthalmic Vis Res：手术治疗难治性假单胞菌感染, objectType=article, longId=137204, objectId=565b13e20479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=565b13e20479, replyNumber=0, likeNumber=75, createdTime=2018-05-05, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=565b13e20479, moduleTitle=J Ophthalmic Vis Res：手术治疗难治性假单胞菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=565b13e20479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528471, encodeId=488515284e1ef, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：PD-1封闭可提高复发性/难治性经典霍奇金淋巴瘤患者的缓解率，并延长其缓解时间，但会增加其免疫毒性风险, objectType=article, longId=137130, objectId=1f0113e13038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f0113e13038, replyNumber=0, likeNumber=75, createdTime=2018-05-05, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f0113e13038, moduleTitle=Blood：PD-1封闭可提高复发性/难治性经典霍奇金淋巴瘤患者的缓解率，并延长其缓解时间，但会增加其免疫毒性风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f0113e13038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528470, encodeId=1f3b15284e070, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：Brentuximab vedotin联合苯达莫司汀作为一线补救疗法用于复发性/难治性HL的疗效和安全性, objectType=article, longId=137013, objectId=ee2913e013e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee2913e013e6, replyNumber=0, likeNumber=66, createdTime=2018-05-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee2913e013e6, moduleTitle=Blood：Brentuximab vedotin联合苯达莫司汀作为一线补救疗法用于复发性/难治性HL的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee2913e013e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528469, encodeId=ddf31528469a2, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=非布司他联合依那西普治疗难治性痛风1例, objectType=article, longId=136620, objectId=0c901366208c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c901366208c, replyNumber=0, likeNumber=93, createdTime=2018-04-28, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c901366208c, moduleTitle=非布司他联合依那西普治疗难治性痛风1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c901366208c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528468, encodeId=2554152846858, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Med Case Reports：克拉霉素“老药新用”使复发难治性多发性骨髓瘤获完全缓解！, objectType=article, longId=136617, objectId=592613661e0d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=592613661e0d, replyNumber=0, likeNumber=0, createdTime=2018-04-28, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=592613661e0d, moduleTitle=J Med Case Reports：克拉霉素“老药新用”使复发难治性多发性骨髓瘤获完全缓解！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=592613661e0d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528467, encodeId=2736152846ecf, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, objectType=article, longId=136587, objectId=884f13658e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=884f13658e71, replyNumber=0, likeNumber=27, createdTime=2018-04-28, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=884f13658e71, moduleTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=884f13658e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528466, encodeId=d6ba152846667, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Am J Gastroenterol：缺乏反流后吞咽诱发蠕动是PPI难治性胃灼热患者的重要特征, objectType=article, longId=136335, objectId=13321363359d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13321363359d, replyNumber=0, likeNumber=82, createdTime=2018-04-26, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13321363359d, moduleTitle=Am J Gastroenterol：缺乏反流后吞咽诱发蠕动是PPI难治性胃灼热患者的重要特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13321363359d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528465, encodeId=4bc3152846530, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=BJU Int：去势难治性前列腺癌（CRPC）患者中，间断性多烯紫杉醇治疗与持续性多烯紫杉醇治疗比较, objectType=article, longId=136275, objectId=22441362e513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22441362e513, replyNumber=0, likeNumber=53, createdTime=2018-04-25, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22441362e513, moduleTitle=BJU Int：去势难治性前列腺癌（CRPC）患者中，间断性多烯紫杉醇治疗与持续性多烯紫杉醇治疗比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22441362e513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528464, encodeId=64551528464f4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Int J Oral Max Surg：口腔手术后下牙槽神经难治性神经感觉障碍的治疗方式及危险因素, objectType=article, longId=136272, objectId=698c1362e281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=698c1362e281, replyNumber=0, likeNumber=68, createdTime=2018-04-25, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=698c1362e281, moduleTitle=Int J Oral Max Surg：口腔手术后下牙槽神经难治性神经感觉障碍的治疗方式及危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=698c1362e281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528463, encodeId=725e1528463e6, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Eur J Cancer：卡巴他赛在激发试验在重度治疗转移难治性前列腺癌患者中的疗效分析, objectType=article, longId=136147, objectId=969713614edb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=969713614edb, replyNumber=0, likeNumber=70, createdTime=2018-04-24, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=969713614edb, moduleTitle=Eur J Cancer：卡巴他赛在激发试验在重度治疗转移难治性前列腺癌患者中的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=969713614edb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

难治性

2020-05-29

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：Quizartinib单药治疗复发性/难治性FLT3-ITD突变型急性髓系白血病的效果和安全性

2018-06-09

freve (审核中...)

前往app查看评论内容

#难治性#

Hypertension：利尿剂对难治性高血压（RfHTN）也是束手无策！

2018-06-08

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet oncol：卡非佐米，每周一次，比每周两次，可显著延长复发性/难治性多发性骨髓瘤患者的无进展存活期

2018-06-04

freve (审核中...)

前往app查看评论内容

#难治性#

JCC：英夫利昔单抗的清除加速与皮质类固醇难治性急性溃疡性结肠炎患者的治疗失败有关

2018-06-04

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet oncol：Quizartinib，FLT3抑制剂，单独用于复发性/难治性急性髓系白血病患者可获得良好疗效

2018-06-02

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet Child Adol Health：依维莫司用于难治性癫痫合并结节性硬化症患儿的辅助治疗

2018-05-26

freve (审核中...)

前往app查看评论内容

#难治性#

突然发呆或是癫痫，难治性癫痫如何治疗？

2018-05-23

freve (审核中...)

前往app查看评论内容

#难治性#

Ann Pharmacother：治疗肠梗阻、ACPO或难治性便秘新斯的明给药方式有讲究

2018-05-20

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：脐带血移植为难治性重度再生障碍性贫血患者带来新的希望

2018-05-17

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：博纳吐单抗用于复发性/难治性急性淋巴细胞白血病成年患者不仅可延长其存活期，还可改善其生活质量

2018-05-11

freve (审核中...)

前往app查看评论内容

#难治性#

J Ophthalmic Vis Res：手术治疗难治性假单胞菌感染

2018-05-05

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：PD-1封闭可提高复发性/难治性经典霍奇金淋巴瘤患者的缓解率，并延长其缓解时间，但会增加其免疫毒性风险

2018-05-05

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：Brentuximab vedotin联合苯达莫司汀作为一线补救疗法用于复发性/难治性HL的疗效和安全性

2018-05-04

freve (审核中...)

前往app查看评论内容

#难治性#

非布司他联合依那西普治疗难治性痛风1例

2018-04-28

freve (审核中...)

前往app查看评论内容

#难治性#

J Med Case Reports：克拉霉素“老药新用”使复发难治性多发性骨髓瘤获完全缓解！

2018-04-28

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究

2018-04-28

freve (审核中...)

前往app查看评论内容

#难治性#

Am J Gastroenterol：缺乏反流后吞咽诱发蠕动是PPI难治性胃灼热患者的重要特征

2018-04-26

freve (审核中...)

前往app查看评论内容

#难治性#

BJU Int：去势难治性前列腺癌（CRPC）患者中，间断性多烯紫杉醇治疗与持续性多烯紫杉醇治疗比较

2018-04-25

freve (审核中...)

前往app查看评论内容

#难治性#

Int J Oral Max Surg：口腔手术后下牙槽神经难治性神经感觉障碍的治疗方式及危险因素

2018-04-25

freve (审核中...)

前往app查看评论内容

#难治性#

Eur J Cancer：卡巴他赛在激发试验在重度治疗转移难治性前列腺癌患者中的疗效分析

2018-04-24

科室
- - 订阅+
  - 更多科室
工具
服务